Product Offerings
Products:
Anticoccidial Drugs: Nicarbazin, Robenidine Hydrochloride, Dinitolmide, Diclazuril, Maduramicin Ammonium
Growth Promoters: Nosiheptide Premix, Kitasamycin Premix
Feed Additives: Ethopabate, Decoquinate Premix
Zhejiang Esigma Biotechnology Co., Ltd., headquartered in Haining, China, is a high-tech enterprise specializing in the research, development, and manufacturing of anticoccidial drugs, growth promoters, and feed additives. The company serves the veterinary pharmaceutical industry, providing high-quality products designed to enhance animal health and productivity.
Core Business and Product Offerings
Zhejiang Esigma Biotechnology Co., Ltd. focuses on producing innovative veterinary pharmaceuticals that meet international quality standards. The company's product portfolio is aimed at improving poultry, livestock, and aquaculture health through effective disease prevention and growth enhancement solutions.
Product Categories
-
Anticoccidial Drugs
- Nicarbazin: Widely used in poultry for the prevention and treatment of coccidiosis.
- Robenidine Hydrochloride: Effective against Eimeria species and commonly applied in poultry feed.
- Dinitolmide: Provides reliable protection against coccidiosis in chickens and turkeys.
- Diclazuril: Broad-spectrum anticoccidial with excellent safety profile for use in multiple animal species.
- Maduramicin Ammonium: A potent ionophore with high efficacy against coccidial parasites.
-
Growth Promoters
- Nosiheptide Premix: An effective growth promoter commonly used in poultry and swine to enhance feed efficiency.
- Kitasamycin Premix: A macrolide antibiotic premix promoting growth and improving feed utilization.
-
Feed Additives
- Ethopabate: A synergist commonly used in combination with other anticoccidials for enhanced efficacy.
- Decoquinate Premix: Used as a preventive treatment against coccidiosis in poultry and cattle.
Specialization and Unique Selling Proposition (USP)
Zhejiang Esigma Biotechnology Co., Ltd. distinguishes itself through its specialization in anticoccidial drugs, particularly those targeting poultry farming. The company's unique selling propositions include:
- Comprehensive Product Range: A broad spectrum of anticoccidials, growth promoters, and feed additives that cater to various animal health needs.
- Stringent Quality Control: Adherence to international standards including GMP (Good Manufacturing Practice) to ensure product safety and efficacy.
- Research & Development Focus: Continuous innovation aimed at improving product efficiency and reducing environmental impact.
- Customization Capability: Ability to develop tailored solutions to meet the specific needs of customers in the animal husbandry industry.
Financial Performance and Market Reach
Zhejiang Esigma Biotechnology Co., Ltd. has established itself as a reliable supplier of veterinary pharmaceuticals across various markets. The company's revenue growth is driven by its strong presence in Asia, particularly in China, Southeast Asia, and South Asia.
The demand for anticoccidial drugs and growth promoters has been increasing steadily, particularly in countries with significant poultry and livestock industries. The company's well-established distribution network and efficient supply chain management contribute to its expanding market reach.
International Shipments Data
The company has recorded consistent growth in its export operations. Major markets include:
- China: Domestic sales continue to be a major revenue contributor, particularly in the poultry and livestock sectors.
- Southeast Asia: High demand for Nicarbazin, Robenidine Hydrochloride, and Diclazuril due to extensive poultry farming.
- South Asia: Increasing demand for growth promoters such as Nosiheptide and Kitasamycin premixes.
Certifications and Compliance Records
Zhejiang Esigma Biotechnology Co., Ltd. has obtained several international certifications demonstrating its commitment to quality and safety, including:
- GMP Certification for veterinary pharmaceuticals.
- ISO9001: Quality Management System Certification.
- FAMI-QS Certification for feed additives.
These certifications ensure the company's adherence to global standards for manufacturing, safety, and quality control.
Capabilities
The company operates advanced manufacturing facilities equipped with state-of-the-art technology to ensure precision and consistency in production. Its research and development team is dedicated to developing new products and improving existing formulations to meet evolving market demands.
The company's ability to provide large-scale production capacity, coupled with efficient logistics management, allows it to cater to both domestic and international markets effectively.
Major Achievements
- Recognition as a leading manufacturer of anticoccidial drugs and feed additives in China.
- Continuous growth in market share within Southeast Asia and South Asia due to high demand for poultry-specific pharmaceuticals.
- Successful development of innovative feed additives aimed at enhancing animal growth and productivity.
Customer Testimonials
The company's products have received positive reviews for their efficacy and consistency. Customers have highlighted the company's commitment to providing high-quality anticoccidial drugs and growth promoters that effectively meet industry needs.
Zhejiang Esigma Biotechnology Co., Ltd. continues to strengthen its position in the veterinary pharmaceutical market through innovation, quality control, and a customer-focused approach aimed at enhancing animal health and productivity worldwide.